Antagonist Activity
Antagonist Activity is a pharmacological phenomenon characterized by the capacity of a ligand to bind to a receptor and inhibit or block the receptor's activation by an agonist, thereby reducing or preventing the downstream biological response.
5K
Publications
294.3K
Citations
22.8K
Authors
3.3K
Institutions
Publications per year
2017–2026
414
Parents
5K
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.8K citations · Full text
Medicine, Neuroscience, Pharmacology +14
Patrick Dorr, Mike Westby, Susan Dobbs et al. · Antimicrobial Agents and Chemotherapy · 2005 · 1.1K citations
1–5 of 5K
22.8K
26
h-index
22
h-index
University of North Carolina at Chapel Hill, United States
15 publications · 1.4K citations
15
h-index
15
h-index
14
h-index
1–5 of 22.8K
3.3K
National Institutes of Health
Bethesda, United States
49 h-index
416 publications
31.8K citations
Inserm
Paris, France
45 h-index
458 publications
24.4K citations
Harvard University
Cambridge, United States
39 h-index
200 publications
23K citations

Centre National de la Recherche Scientifique
Paris, France
38 h-index
400 publications
21.8K citations
University of Michigan
Ann Arbor, United States
37 h-index
205 publications
13.1K citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
35 h-index
380 publications
21.4K citations
Eli Lilly (United States)
Indianapolis, United States
29 h-index
290 publications
15.7K citations
Pfizer (United States)
New York, United States
27 h-index
231 publications
25.6K citations
1–8 of 3.3K
363 publications · 24.8K citations
84
h-index
BJP · 372 publications · 23.3K citations
80
h-index
405 publications · 21.3K citations
73
h-index
JBC · 123 publications · 12.5K citations
65
h-index
PNAS · 93 publications · 11.2K citations
60
h-index
1–5